Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial. - Sehgal K; Pappa T; Shin KY; Schiantarelli J; Liu M; Ricker C; Besson NR; Jones SM; Welsh EL; Pfaff KL; Barletta JA; Park J; et al. (JAMA oncology, 2024)